Yes, good reminder of what Doctor Prins shared many years ago about using identified targets selected by amplified T-cell target populations created by exposure to DCVax-L as the basis for creating an allogenic, off the shelf preventative cancer vaccine. “An ounce of prevention is worth a pound if cure” (except to those who need the cure… now). Dr. Linda Liau and NWBO understand this very well. Best wishes.
Market Data 
Markets 
